Å·ÃÀAV

Introduction

Day One

Track 1: Discovery & Development: Cell & Combination Therapies
Track 2: Biomarkers & Precision Medicine In Immuno-Oncology
Track 3: Autoimmunity Mechanisms & Novel Treatments

Day Two

Track 1: Discovery & Development: Intratumoral Immunotherapies & Antibody Therapies
Track 2: Translational Development
Track 3: Preclinical & Clinical Development

Deadlines

• Mar 01 2023
  Standard registration deadline

  

Useful links

Speakers

• Colleen Winstead Director of Immunology
  Epitopea, United Kingdom
• Yaara Ofir-Rosenfield Director of Translational Oncology
  STORM Therapeutics, United Kingdom
• Duncan Howie Director of Immunology
  EnaraBio, United Kingdom
• Tobias Speck Vice President, Product Development
  CanVirex, United Kingdom
• Øystein Rekdal Chief Executive Officer
  Lytix Biopharma AS, United Kingdom
• Angelica Loskog Chief Executive Officer
  Lokon Pharma AB, United Kingdom

---

Venue

Novotel London West

Novotel London West, Hammersmith International Centre , 1 Shortlands, Hammersmith, London, W6 8DR, United Kingdom

Useful links

Organised by

Contact information

Bromwyn Westmore
Oxford Global Conferences
+441865 248455
Contact us by email

---